dstock07734, I agree with your post also. I even tweeted about what the implications are for DCVax-L and DCVax Direct, and why I believe both are tumor and tissue agnostic:
$NWBO#DCVax is tumor & tissue agnostic for all or most solid tumor cancers. Not because it only targets 1 or 2, or a few of each patient’s cancer tumors’ biomarkers, peptides, antigens & neoantigens, #DCVax is tissue agnostic because it is individualized & personalized for each… pic.twitter.com/piCyxsjBg8
Thanks dstock, I think many investors missed this important study. The natural immune response to brain cancer without dcvax recognizes and attacks 20 peptides it sees as foreign. But if DCVax is introduced to the tumor then the imunne system recognizes up to 1200 foriegn peptides that can be attacked by the T cells. This proactive proof of showing how dcvax works blocks the arguments of the forces working against approvoal.